Effects of Code Sepsis Implementation on Emergency Department (ED) Sepsis Care
Code Sepsis
2 other identifiers
interventional
180,402
1 country
3
Brief Summary
Sepsis is a life-threatening complication of infection that can be difficult to recognize and treat promptly. Timely administration of antibiotics for emergency department (ED) patients with sepsis is challenging. The goal of this study is to determine the potential effectiveness and unintended consequences of reorganizing ED care for patients with suspected sepsis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable sepsis
Started Nov 2018
Longer than P75 for not_applicable sepsis
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 13, 2018
CompletedFirst Submitted
Initial submission to the registry
October 31, 2019
CompletedFirst Posted
Study publicly available on registry
November 4, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 23, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 28, 2023
CompletedResults Posted
Study results publicly available
March 5, 2024
CompletedMarch 5, 2024
February 1, 2024
4.2 years
October 31, 2019
January 11, 2024
February 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Door-to-antibiotic Time
Time from sepsis patients' emergency department arrival to intravenous (or equivalent) antibiotic initiation
Up to 24 hours from ED arrival (an average of 3 hours)
Secondary Outcomes (5)
All-cause 30-day Mortality
30 days after ED arrival
All-cause 1-year Mortality
1 year after ED arrival
All-cause In-hospital Mortality
From the time of admission to hospital discharge (up to 1 year, average 14 days)
Hospital Charges
From the time of admission to hospital discharge (up to 1 year, average 14 days)
Hospital Length of Stay
From the time of admission to hospital discharge (up to 1 year, average 14 days)
Other Outcomes (8)
Antibiotic Utilization'
Up to 24 hours from ED arrival (an average of 6 hours)
Adverse Effects of Antibiotics (Sepsis Patients)
From the time of ED arrival to hospital discharge (up to 1 year, average 14 days)
Adverse Effect of Antibiotics (All ED Patients)
From the time of ED arrival to hospital discharge (up to 1 year, average 14 days)
- +5 more other outcomes
Study Arms (4)
Pre-implementation usual care (intervention site)
NO INTERVENTIONAdult patients age ≥18 years who receive usual care after presenting to the ED of the intervention hospital emergency department before implementation of sepsis care reorganization (Code Sepsis implementation). The primary analysis will focus on the subset of patients with sepsis.
Code Sepsis post-implementation (intervention site)
EXPERIMENTALAdult patients age ≥18 years presenting to the ED of the intervention hospital emergency department after implementation of sepsis care reorganization (Code Sepsis implementation). The primary analysis will focus on the subset of patients with sepsis.
Pre-implementation usual care (control sites)
NO INTERVENTIONAdult patients age ≥18 years who receive usual care after presenting to the ED of the control hospital emergency department before implementation of sepsis care reorganization (Code Sepsis implementation) at the intervention hospital. The primary analysis will focus on the subset of patients with sepsis.
Post-implementation usual care (control sites)
NO INTERVENTIONAdult patients age ≥18 years who receive usual care after presenting to the ED of the control hospital emergency department after implementation of sepsis care reorganization (Code Sepsis implementation) at the intervention hospital. The primary analysis will focus on the subset of patients with sepsis.
Interventions
Implementation of a coordinated, structured, multidisciplinary team-based protocol for initial evaluation and treatment of ED patients with suspected sepsis.
Eligibility Criteria
You may qualify if:
- Adult (age ≥18 years)
- ED patient at Intermountain Medical Center, Utah Valley Hospital, Dixie Regional Medical Center
- Arrival to study emergency department (ED) during study period of 11/13/2018 to 2/12/2021.
You may not qualify if:
- (1) Trauma patient
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Intermountain Medical Center
Murray, Utah, 84107, United States
Utah Valley Hospital
Provo, Utah, 84604, United States
Dixie Regional Medical Center
St. George, Utah, 84790, United States
Related Publications (1)
Peltan ID, Bledsoe JR, Jacobs JR, Groat D, Klippel C, Adamson M, Hooper GA, Tinker NJ, Foster RA, Stenehjem EA, Moores Todd TD, Balls A, Avery J, Brunson G, Jones J, Bair J, Dorais A, Samore MH, Hough CL, Brown SM. Effectiveness and Safety of an Emergency Department Code Sepsis Protocol: A Pragmatic Clinical Trial. Ann Am Thorac Soc. 2024 Nov;21(11):1560-1571. doi: 10.1513/AnnalsATS.202403-286OC.
PMID: 38996086DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Director, Office of Research
- Organization
- Intermountain Health
Study Officials
- PRINCIPAL INVESTIGATOR
Ithan Peltan, MD
Intermountain Health Care, Inc.
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Investigator
Study Record Dates
First Submitted
October 31, 2019
First Posted
November 4, 2019
Study Start
November 13, 2018
Primary Completion
January 23, 2023
Study Completion
December 28, 2023
Last Updated
March 5, 2024
Results First Posted
March 5, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will share
In order to protect patient privacy and comply with relevant regulations, identified data will be unavailable. Requests for deidentified data from qualified researchers with appropriate ethics board approvals and relevant data use agreements will be processed by the Intermountain Office of Research, officeofresearch@imail.org.